• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名患有X连锁Alport综合征的患者建立诱导多能干细胞系,该患者在IV型胶原α5链基因中携带半合子剪接变体(NM_033380;c.929[外显子16]delG)。

Establishment of an induced pluripotent stem cell line from a patient with X-linked Alport syndrome carrying a hemizygous splicing variant (NM_033380; c.929[exon 16]delG) in the collagen type IV alpha 5 chain gene.

作者信息

Zhang Denglu, Li KaiLin, Yang XianZhen, Wang Haitao, Yu Xin

机构信息

Central Laboratory, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China; Shandong Key Laboratory of Dominant Diseases of Traditional Chinese Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014,China.

Central Research Laboratory, Institute of Medical Science, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, China.

出版信息

Stem Cell Res. 2024 Oct;80:103488. doi: 10.1016/j.scr.2024.103488. Epub 2024 Jul 2.

DOI:10.1016/j.scr.2024.103488
PMID:39053318
Abstract

X-linked hereditary Alport syndrome (XLAS) type 1 (OMIM: 301050) results from a pathogenic variant in the collagen type IV alpha 5 chain (COL4A5) gene.A human induced pluripotent stem cell (iPSC) line was generated from peripheral blood mononuclear cells of a 7-year-old male patient with XLAS using non-integrating episomal vector technique. The male donor had a heterozygous variant in the COL4A5 gene. The resulting iPSC line has a standard karyotype, can express pluripotent biomarkers, and is able to create germ layers in vivo. It can serve as a valuable cellular model for investigating the underlying mechanisms of XLAS.

摘要

X连锁遗传性奥尔波特综合征1型(XLAS,OMIM:301050)由IV型胶原α5链(COL4A5)基因的致病性变异引起。使用非整合型附加体质粒载体技术,从一名7岁XLAS男性患者的外周血单个核细胞中生成了人诱导多能干细胞(iPSC)系。该男性供体的COL4A5基因存在杂合变异。所得的iPSC系具有标准核型,可表达多能性生物标志物,并能够在体内形成胚层。它可作为研究XLAS潜在机制的宝贵细胞模型。

相似文献

1
Establishment of an induced pluripotent stem cell line from a patient with X-linked Alport syndrome carrying a hemizygous splicing variant (NM_033380; c.929[exon 16]delG) in the collagen type IV alpha 5 chain gene.从一名患有X连锁Alport综合征的患者建立诱导多能干细胞系,该患者在IV型胶原α5链基因中携带半合子剪接变体(NM_033380;c.929[外显子16]delG)。
Stem Cell Res. 2024 Oct;80:103488. doi: 10.1016/j.scr.2024.103488. Epub 2024 Jul 2.
2
Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.从一位 X 连锁 Alport 综合征患者中生成诱导多能干细胞系 (GWCMCi002-A),该患者在 COL4A5 基因中存在杂合剪接突变 (NM_000495.4, c. 1517-1 G > T)。
Stem Cell Res. 2021 May;53:102388. doi: 10.1016/j.scr.2021.102388. Epub 2021 May 11.
3
Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).源自两名X连锁遗传性肾炎(XLAS)患者的无整合诱导多能干细胞系的产生。
Stem Cell Res. 2017 Dec;25:291-295. doi: 10.1016/j.scr.2017.08.019. Epub 2017 Sep 9.
4
Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.从一名患有X连锁Alport综合征的患者中生成诱导多能干细胞系(SHCDNRi001-A),该患者在COL4A5基因中携带杂合的p.G409S(c.1225 G>A)突变。
Stem Cell Res. 2020 May;45:101833. doi: 10.1016/j.scr.2020.101833. Epub 2020 May 6.
5
Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.COL4A5 基因两种变异引起的 Alport 综合征的遗传与分子动力学分析。
BMC Med Genomics. 2023 Aug 18;16(1):192. doi: 10.1186/s12920-023-01623-7.
6
Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.使用基于质粒载体的 CRISPR/Cas9 系统生成 COL4A5 杂合突变人胚胎干细胞系(WAe009-A-58)。
Stem Cell Res. 2021 Aug;55:102481. doi: 10.1016/j.scr.2021.102481. Epub 2021 Aug 9.
7
Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.从 X 连锁 Alport 综合征患者中生成两个诱导多能干细胞系。
Stem Cell Res. 2021 May;53:102343. doi: 10.1016/j.scr.2021.102343. Epub 2021 Apr 17.
8
Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.杂合致病性COL4A3或COL4A4变异对X连锁Alport综合征患者的影响。
Mol Genet Genomic Med. 2019 May;7(5):e647. doi: 10.1002/mgg3.647. Epub 2019 Mar 18.
9
X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.与同义p.Gly292Gly突变相关的X连锁Alport综合征改变了IV型胶原α5链基因的剪接受体位点。
Clin Exp Nephrol. 2016 Oct;20(5):699-702. doi: 10.1007/s10157-015-1197-9. Epub 2015 Nov 18.
10
Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.使用微基因检测方法对 X 连锁型 Alport 综合征中的同义 COL4A5 变异进行致病性评估。
Mol Genet Genomic Med. 2020 Aug;8(8):e1342. doi: 10.1002/mgg3.1342. Epub 2020 Jun 16.